117 related articles for article (PubMed ID: 8583839)
1. Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition.
Ondrey FG; Juhn SK; Adams GL
Laryngoscope; 1996 Feb; 106(2 Pt 1):129-34. PubMed ID: 8583839
[TBL] [Abstract][Full Text] [Related]
2. Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal antiinflammatory drugs.
Scioscia KA; Snyderman CH; Rueger R; Reddy J; D'Amico F; Comsa S; Collins B
Am J Otolaryngol; 1997; 18(1):1-8. PubMed ID: 9006670
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth of a murine squamous cell carcinoma by a cyclooxygenase inhibitor increases leukotriene B4 production.
Snyderman CH; Abbas MM; Wagner R; D'Amico F
Arch Otolaryngol Head Neck Surg; 1995 Sep; 121(9):1017-20. PubMed ID: 7646853
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic acid metabolites in saliva of patients with squamous cell carcinoma of the head and neck.
Malone JP; Snyderman CH
Oral Surg Oral Med Oral Pathol; 1994 Jun; 77(6):636-40. PubMed ID: 8065730
[TBL] [Abstract][Full Text] [Related]
5. Effects of arachidonic acid metabolites in a murine model of squamous cell carcinoma.
Scioscia KA; Snyderman CH; D'Amico F; Comsa S; Rueger R; Light B
Head Neck; 2000 Mar; 22(2):149-55. PubMed ID: 10679902
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of 13-cis retinoic acid and arachidonic acid cascade inhibitors on growth of head and neck squamous cell carcinoma in vitro.
Spingarn A; Sacks PG; Kelley D; Dannenberg AJ; Schantz SP
Otolaryngol Head Neck Surg; 1998 Feb; 118(2):159-64. PubMed ID: 9482545
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis.
Zhang DY; Wu J; Ye F; Xue L; Jiang S; Yi J; Zhang W; Wei H; Sung M; Wang W; Li X
Cancer Res; 2003 Jul; 63(14):4037-43. PubMed ID: 12874003
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression.
Koontongkaew S; Monthanapisut P; Saensuk T
Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):100-8. PubMed ID: 20654727
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate.
Johnson FM; Yang P; Newman RA; Donato NJ
J Exp Ther Oncol; 2004 Dec; 4(4):317-25. PubMed ID: 15844661
[TBL] [Abstract][Full Text] [Related]
10. Tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck: mechanisms of enhancement using prostaglandin synthetase inhibitors.
Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
Adv Exp Med Biol; 1997; 400B():1013-24. PubMed ID: 9547657
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
12. Comparison of arachidonic acid metabolism by normal, precancerous and neoplastic epithelial cell lines of the upper aerodigestive tract.
Snyderman C; Schwartz D; Bonomi C; Wagner R
Adv Exp Med Biol; 1997; 400A():93-8. PubMed ID: 9547542
[No Abstract] [Full Text] [Related]
13. Arachidonic acid metabolism and cell proliferation in rat mammary carcinoma cells treated with indomethacin.
Tripathi SC; Vosseller KA; McCormick DL
Biochim Biophys Acta; 1996 May; 1316(1):5-7. PubMed ID: 8634343
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulation of patients with head and neck cancer. In vitro and preliminary clinical experiences.
Hirsch B; Johnson JT; Rabin BS; Thearle PB
Arch Otolaryngol; 1983 May; 109(5):298-301. PubMed ID: 6847479
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclooxygenase-2 activity in head and neck cancer cells by genistein.
Ye F; Wu J; Dunn T; Yi J; Tong X; Zhang D
Cancer Lett; 2004 Jul; 211(1):39-46. PubMed ID: 15194215
[TBL] [Abstract][Full Text] [Related]
16. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
17. Arachidonic acid metabolism: a primer for head and neck surgeons.
Ondrey FG
Head Neck; 1998 Jul; 20(4):334-49. PubMed ID: 9588707
[TBL] [Abstract][Full Text] [Related]
18. Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck.
Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
Arch Otolaryngol Head Neck Surg; 1992 May; 118(5):526-8. PubMed ID: 1571128
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of arachidonic acid metabolism potentiate tumour necrosis factor-alpha-induced apoptosis in HL-60 cells.
Vondrácek J; Stika J; Soucek K; Minksová K; Bláha L; Hofmanová J; Kozubík A
Eur J Pharmacol; 2001 Jul; 424(1):1-11. PubMed ID: 11470254
[TBL] [Abstract][Full Text] [Related]
20. Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.
Zhang X; Chen ZG; Choe MS; Lin Y; Sun SY; Wieand HS; Shin HJ; Chen A; Khuri FR; Shin DM
Clin Cancer Res; 2005 Sep; 11(17):6261-9. PubMed ID: 16144930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
